The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)

The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)

[at noodls] – PARSIPPANY, NJ — (MARKETWIRE) — 02/08/13 — The Medicines Company (NASDAQ: MDCO) announced today that the global license and two-year collaboration for Recothrom®, a recombinant thrombin approved by … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view

Share this post